We report a 67-year-old male with pneumoniae in which Chlamydia pneumoniae was identified by serologic studies as the causative agent. After initial treatment failure with amoxicillin + clavulanic acid, pneumonia was successfully treated with the administration or oral azithromycin, 500 mg per day, for three days. Azithromycin is a new macrolide which has a long half-life and superior action to erythromcyin. It provides a new and alternative choice in the treatment of Chlamydia pneumoniae infection in the future.
|頁（從 - 到）||642-644|
|期刊||Journal of the Formosan Medical Association|
|出版狀態||已發佈 - 1994|
ASJC Scopus subject areas
- 醫藥 (全部)